(Q29365799)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243941%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

title

Exploiting virus-like particles as innovative vaccines against emerging viral infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243941%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

author name string

Hotcherl Jeong

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243941%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Baik Lin Seong

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243941%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

publication date

28 February 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243941%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Microbiology

4 April 2020

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243941%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243941%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243941%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

page(s)

220-230

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243941%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12275-017-7058-3

4 April 2020

exact match

0 references

cites work

A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Vaccination greatly reduces disease, disability, death and inequity worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Engineering thermal stability in RNA phage capsids via disulphide bonds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Neutralizing antiviral B cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Combinatorial approach to hepadnavirus-like particle vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Vaccine and adjuvant design for emerging viruses: mutations, deletions, segments and signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Escherichia coli-based cell-free synthesis of virus-like particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Efficient disulfide bond formation in virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

VIPERdb2: an enhanced and web API enabled relational database for structural virology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Virus-like display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Plant-derived virus-like particles as vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Protein solubility and folding enhancement by interaction with RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Protein folding in vivo revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

RNA-mediated chaperone type for de novo protein folding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Modeling the competition between aggregation and self-assembly during virus-like particle processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Next generation vaccines and vectors: Designing downstream processes for recombinant protein-based virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Insect cells as a production platform of complex virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Engineered mutations change the structure and stability of a virus-like particle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

The atomic structure of the bluetongue virus core

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Noroviruses: the perfect human pathogens?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

N-Glycosylation of secretion enhancer peptide as influencing factor for the secretion of target proteins from Saccharomyces cerevisiae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

The coming of age of virus-like particle vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Protein delivery using engineered virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Virus-like particles as universal influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

A lentiviral strategy for highly efficient retrograde gene transfer by pseudotyping with fusion envelope glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

SV40 virus-like particles as an effective delivery system and its application to a vaccine carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Design of hybrid lipid/retroviral-like particle gene delivery vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Yeast as an expression system for producing virus-like particles: what factors do we need to consider?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Physical stabilization of Norwalk virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Computer-aided antibody design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Bioprocessing of plant-derived virus-like particles of Norwalk virus capsid protein under current Good Manufacture Practice regulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Novel secretion system of recombinant Saccharomyces cerevisiae using an N-terminus residue of human IL-1 beta as secretion enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Viral vectors for production of recombinant proteins in plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

DNA vaccines: recent developments and future possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Nanoparticles target distinct dendritic cell populations according to their size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Molecular pharming - VLPs made in plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Recombinant-expressed virus-like particle pseudotypes as an approach to vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

The use of viral vectors to produce hepatitis B virus core particles in plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Mechanisms of human papillomavirus-induced oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Simultaneous expression of recombinant proteins in the insect cell-baculovirus system: production of virus-like particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Multiscaling for systems with a broad continuum of characteristic lengths and times: Structural transitions in nanocomposites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Noroviruses: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Molecular Pharming: future targets and aspirations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Versatile RHDV virus-like particles: incorporation of antigens by genetic modification and chemical conjugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Tandem fusion of hepatitis B core antigen allows assembly of virus-like particles in bacteria and plants with enhanced capacity to accommodate foreign proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

X-ray crystallographic structure of the Norwalk virus capsid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Quality by design for biopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

In vitro-reassembled plant virus-like particles for loading of polyacids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Molecular and process design for rotavirus-like particle production in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

On the effect of thermodynamic equilibrium on the assembly efficiency of complex multi-layered virus-like particles (VLP): the case of rotavirus VLP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Self-assembly of purified polyomavirus capsid protein VP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Human parvovirus B19 virus-like particles: In vitro assembly and stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Virus-like particles produced in plants as potential vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Biological gene delivery vehicles: beyond viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

The influenza pandemic of 2009: lessons and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Stabilization of human papillomavirus virus-like particles by non-ionic surfactants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Influenza virus vaccine based on the conserved hemagglutinin stalk domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Molecular farming in plants: host systems and expression technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Use of hepadnavirus core proteins as vaccine platforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

The crystal structure of the human hepatitis B virus capsid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Utilizing dynamic light scattering as a process analytical technology for protein folding and aggregation monitoring in vaccine manufacturing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Virus-induced humoral immunity: on how B cell responses are initiated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Construction and characterization of virus-like particles: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Molecular energetics in the capsomere of virus-like particle revealed by molecular dynamics simulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Energetic changes caused by antigenic module insertion in a virus-like particle revealed by experiment and molecular dynamics simulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Purification of norovirus-like particles (VLPs) by ion exchange chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-017-7058-3

Innate signaling regulates cross-priming at the level of DC licensing and not antigen presentation

21 January 2018

1 reference

12 December 2020

The 2016 Vaccine Development Pipeline: A special issue from the World Health Organization Product Development for Vaccine Advisory Committee (PDVAC)

1 reference

12 December 2020

Plant-based vaccines against viruses.

1 reference

12 December 2020

The influence of antigen organization on B cell responsiveness

1 reference

12 December 2020

Incidence of acute gastroenteritis and role of norovirus, Georgia, USA, 2004-2005.

1 reference

12 December 2020

Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7–9th Sep 2015

1 reference

12 December 2020

Disassembly and reassembly improves morphology and thermal stability of human papillomavirus type 16 virus-like particles

1 reference

12 December 2020

Quantitative disassembly and reassembly of human papillomavirus type 11 viruslike particles in vitro.

1 reference

12 December 2020

Comparative analysis of recombinant Human Papillomavirus 8 L1 production in plants by a variety of expression systems and purification methods

1 reference

12 December 2020

DNA vaccines--back in the saddle again?

1 reference

12 December 2020

Enhanced secretion of human granulocyte colony-stimulating factor directed by a novel hybrid fusion peptide from recombinant Saccharomyces cerevisiae at high cell concentration

1 reference

12 December 2020

Conformational stability and disassembly of Norwalk virus-like particles. Effect of pH and temperature

1 reference

12 December 2020

Innate immunity mediates follicular transport of particulate but not soluble protein antigen

1 reference

12 December 2020

The 2009 pandemic influenza virus: where did it come from, where is it now, and where is it going?

1 reference

12 December 2020

Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein

1 reference

12 December 2020

10.1007/S12275-017-7058-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243941%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

4 April 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28243941%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

1 reference